I've got mine...
######
Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
https://www.clinicaltrials.gov/ct2/show/NCT04739410
#############
Pepcid
TAIPEI (Taiwan News) — A cheap drug originally designed to relieve heartburn but also well known in Asian-American communities as an “antidote” for the “Asian flush” is currently being studied in the U.S. as a treatment for the Wuhan coronavirus (COVID-19).
CNN on Monday (April 27) cited the president of Feinstein Institutes for Medical Research at Northwell Health, Dr. Kevin Tracey, as saying that preliminary results of a clinical trial to use famotidine to treat coronavirus patients in New York City could be available in a few weeks. Tracy said that 187 patients have signed on to the trial so far and that the institute hopes to enroll 1,174.
Unlike the normal dosage in the form of a pill, the patients are being given the drug in large doses intravenously, approximately nine times the prescribed amount for heartburn. The institute decided to begin trials after an infectious disease specialist at Massachusetts General Hospital, Dr. Michael Callahan, discovered significant results with coronavirus patients in China.
Initially, he and his Chinese colleagues were mystified to find that low-income patients who had been taking medication for chronic heartburn were faring much better than their wealthy counterparts with the same underlying stomach ailment who were taking a more expensive drug. They then realized that the poor patients were taking famotidine, the active ingredient in Pepcid (among other brand names), while the richer patients were taking the more costly omeprazole (Prilosec).
Read More:
https://www.taiwannews.com.tw/en/news/3923757
LucyT wrote:
“######
Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
https://www.clinicaltrials.gov/ct2/show/NCT04739410
“
Note the third tab.
No results included. (Why not?)
50 people in a month-long study.
Thanx for the link